Details

Last Funding Type

Series D

Last Funding Money Raised

¥264M

Industries

Biotechnology,Medical,Therapeutics

Founded date

Jan 1, 2013

Number Of Employee

1 - 10

Operating Status

Active

TenNor Therapeutics is a clinical stage, product development company with a sharp focus on unmet medical needs in the area of infectious diseases. The company possesses a dual-acting drug discovery platform with several innovative products in various stages of preclinical and clinical development. The company is developing new drugs for the treatment of Helicobacter pylori infections, prosthetic joint infections, multidrug-resistant Gram-negative infections and some other common and serious infectious diseases.